Skip to main content
SpringerLink
Log in

Combined Two-Dose Hepatitis A and B Vaccine (AmBirix™)

A Viewpoint by Pierre Van Damme

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Control and Prevention of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium

    Pierre Van Damme

Authors
  1. Pierre Van Damme
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Use of tradenames is for product identification purposes only and does not imply endorsement.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Damme, P. Combined Two-Dose Hepatitis A and B Vaccine (AmBirix™). Drugs 63, 214 (2003). https://doi.org/10.2165/00003495-200363020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200363020-00007

Search

Navigation